Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.

Slides:

Advertisements

Similar presentations

Copyright © 2014 American Medical Association. All rights reserved.

Advertisements

Prognostic Value of Morning Blood Pressure Surge in Clinical Events: A Meta-analysis of Longitudinal Studies Jun-Chao Xie, Han Yan, Yan-Xin Zhao, PhD,

The “occasional open heart surgeon” revisited

Robert A. Guyton, MD The Annals of Thoracic Surgery

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational.

Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Chirag Bavishi, MD, MPH,

Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with.

Percutaneous coronary invervention versus coronary artery bypass grafting: A meta- analysis Yolba Smit, MD, MSc, Joan Vlayen, MD, Hetty Koppenaal, MD,

Equivalent outcomes after coronary artery bypass graft surgery performed by consultant versus trainee surgeons: A systematic review and meta-analysis

Pre-existing psychological depression confers increased risk of adverse cardiovascular outcomes following cardiac surgery: A systematic review and meta-analysis

Preoperative Prophylactic Intraaortic Balloon Pump Reduces the Incidence of Postoperative Acute Kidney Injury and Short-Term Death of High-Risk Patients.

Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis S Hajibandeh, S Hajibandeh,

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Meta-analysis of minimally invasive coronary artery bypass versus drug-eluting stents for isolated left anterior descending coronary artery disease Ralf.

Robert A. Guyton, MD The Annals of Thoracic Surgery

Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: A meta-analysis Peter Donndorf, MD, Guenther Kundt, PhD,

Standardizing definitions for hybrid coronary revascularization

Do higher-risk patients benefit from off-pump coronary artery bypass grafting? Evidence from an ecologic analysis of randomized trials Oliver Kuss, PhD,

The impact of incomplete revascularization and angiographic patency on midterm results after off-pump coronary artery bypass grafting Jota Nakano, MD,

Should clopidogrel be discontinued before coronary artery bypass grafting for patients with acute coronary syndrome? A systematic review and meta-analysis

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

Unprotected Left Main Coronary Artery Stenting Versus Coronary Artery Bypass Graft Surgery Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Norikazu Kawai,

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Off-Pump Versus On-Pump Coronary Revascularization: Meta-Analysis of Mid- and Long-Term Outcomes Umar A.R. Chaudhry, MBBS, Leanne Harling, MRCS, Christopher.

Off-Pump Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention: A Meta-Analysis of Randomized and Nonrandomized Studies J. James Edelman,

Juan A. Crestanello, MD, Richard C. Daly, MD

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Lower graft patency after off-pump than on-pump coronary artery bypass grafting: An updated meta-analysis of randomized trials Hisato Takagi, MD, PhD,

Why surgery won the SYNTAX trial and why it matters

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Beating-Heart Versus Conventional On-Pump Coronary Artery Bypass Grafting: A Meta- Analysis of Clinical Outcomes Umar A.R. Chaudhry, MBBS, Leanne Harling,

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Off-pump versus on-pump coronary artery bypass grafting: A systematic review and meta-analysis of propensity score analyses Oliver Kuss, PhD, Benita.

Multilevel data analysis: What? Why? How?

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Yousef Rezaei, MD American Journal of Kidney Diseases

Gentamicin-collagen sponge reduces the risk of sternal wound infections after heart surgery: Meta-analysis Mariusz Kowalewski, MD, Wojciech Pawliszak,

Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Performance of the European System for Cardiac Operative Risk Evaluation II: A meta- analysis of 22 studies involving 145,592 cardiac surgery procedures

Anaortic off-pump coronary artery bypass grafting: The criterion standard for minimization of neurologic injury J. James Edelman, BSc(Hons), MBBS(Hons),

Angiographic outcomes of radial artery versus saphenous vein in coronary artery bypass graft surgery: A meta-analysis of randomized controlled trials

Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease Hidde Jongsma, MD, Joost.

Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?

Preoperative atrial fibrillation portends poor outcomes after coronary bypass graft surgery: A systematic review and meta-analysis Akshat Saxena, MBBS,

Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD

For everything there is a season

Survival probability loss from percutaneous coronary intervention compared with coronary artery bypass grafting across age groups Umberto Benedetto,

To bypass or stent? The changing rules of an advancing game

One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: A.

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Stent Versus Off-Pump Coronary Bypass Grafting in the Second-Generation Drug- Eluting Stent Era Gijong Yi, MD, PhD, Hyun-Chel Joo, MD, Young-Nam Youn,

Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: Duminda N Wijeysundera, MD, Jennifer S Naik, MD, W Scott Beattie, MD,

Meta-analysis of randomized trials on the efficacy of posterior pericardiotomy in preventing atrial fibrillation after coronary artery bypass surgery

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

M. Hassan Murad, MD, MPH, David N. Flynn, BS, Mohamed B

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

Right internal thoracic artery versus radial artery as the second best arterial conduit: Insights from a meta-analysis of propensity-matched data on long-term.

Gentamicin collagen sponges for the prevention of sternal wound infection: A meta- analysis of randomized controlled trials Michael N. Mavros, MD, Pantelis.

Figure 7. Subgroup analysis according to the study design and support of CPB during CABG. The study design and support of CPB did not affect the results.

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: A randomized trial Vito A. Mannacio, MD, Domenico Iorio, MD, Vincenzo.

Presentation transcript:

Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized studies Tristan D. Yan, BSc(Med), MBBS, PhD, Ratnasari Padang, MBBS, Chin Poh, Christopher Cao, BSc(Med), MBBS, Michael K. Wilson, MBBS, Paul G. Bannon, MBBS, PhD, Michael P. Vallely, MBBS, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 5, Pages 1134-1144 (May 2011) DOI: 10.1016/j.jtcvs.2010.07.001 Copyright © 2011 Terms and Conditions

Figure 1 Forest plot of the relative risk (RR) of all-cause mortality after drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for coronary artery disease. The estimate of the RR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% confidence interval (CI). On each line, the numbers of events as a fraction of the total number randomized are shown for both treatment groups. For each subgroup, the sum of the statistics, along with the summary RR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within a subgroup is given below the summary statistics. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1134-1144DOI: (10.1016/j.jtcvs.2010.07.001) Copyright © 2011 Terms and Conditions

Figure 2 Forest plot of the relative risk (RR) of all-cause stroke after drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for coronary artery disease. The studies were analyzed according to the type of morbidity and mortality. The estimate of the RR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% confidence interval (CI). On each line, the numbers of events as a fraction of the total number randomized are shown for both treatment groups. For each subgroup, the sum of the statistics, along with the summary RR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within a subgroup is given below the summary statistics. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1134-1144DOI: (10.1016/j.jtcvs.2010.07.001) Copyright © 2011 Terms and Conditions

Figure 3 Forest plot of the relative risk (RR) of myocardial infarction after drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for coronary artery disease. The estimate of the RR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% confidence interval (CI). On each line, the numbers of events as a fraction of the total number randomized are shown for both treatment groups. For each subgroup, the sum of the statistics, along with the summary RR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within a subgroup is given below the summary statistics. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1134-1144DOI: (10.1016/j.jtcvs.2010.07.001) Copyright © 2011 Terms and Conditions

Figure 4 Forest plot of the relative risk (RR) of repeat revascularization after drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for coronary artery disease. The estimate of the RR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% confidence interval (CI). On each line, the numbers of events as a fraction of the total number randomized are shown for both treatment groups. For each subgroup, the sum of the statistics, along with the summary RR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within a subgroup is given below the summary statistics. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1134-1144DOI: (10.1016/j.jtcvs.2010.07.001) Copyright © 2011 Terms and Conditions

Figure 5 Forest plot of the relative risk (RR) of major cardiac and cerebrovascular events (MACCE) after drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for coronary artery disease. The estimate of the RR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% confidence interval (CI). On each line, the numbers of events as a fraction of the total number randomized are shown for both treatment groups. For each subgroup, the sum of the statistics, along with the summary RR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within a subgroup is given below the summary statistics. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1134-1144DOI: (10.1016/j.jtcvs.2010.07.001) Copyright © 2011 Terms and Conditions

Figure 6 Forest plot of the relative risk (RR) of 30-day myocardial infarction, myocardial infarction at last follow-up, repeat revascularization, and 30-day and 12-month major cardiac and cerebrovascular events (MACCE) after drug-eluting stents (DES) versus coronary artery bypass grafting (CABG) for multivessel coronary artery disease. The estimate of the RR of each trial corresponds to the middle of the squares, and the horizontal line shows the 95% confidence interval (CI). On each line, the numbers of events as a fraction of the total number randomized are shown for both treatment groups. For each subgroup, the sum of the statistics, along with the summary RR, is represented by the middle of the solid diamonds. A test of heterogeneity between the trials within a subgroup is given below the summary statistics. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1134-1144DOI: (10.1016/j.jtcvs.2010.07.001) Copyright © 2011 Terms and Conditions